By Dr John Walter Frew

Journal articles

Frew JW, 2019, 'Assessing the efficacy of new biologic therapies in hidradenitis suppurativa: consistency vs. bias in outcome measures in moderate and severe disease', Journal of the European Academy of Dermatology and Venereology, 33, pp. e298 - e300, http://dx.doi.org/10.1111/jdv.15572

Frew JW; Navrazhina K; Marohn M; Lu PJC; Krueger JG, 2019, 'Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa', Experimental Dermatology, 28, pp. 886 - 891, http://dx.doi.org/10.1111/exd.13978

Frew JW, 2019, 'Lack of photographic documentation undermines assessment of hidradenitis suppurativa phenotypes: reply from the author', British Journal of Dermatology, 181, pp. 225, http://dx.doi.org/10.1111/bjd.17934

Frew JW, 2019, 'Hidradenitis suppurativa and diabetes: big data bias masks a true association', Clinical and Experimental Dermatology, 44, pp. e151 - e152, http://dx.doi.org/10.1111/ced.13954

Slape D; Tang J; Lawless R; McCrossin I; Frew JW, 2019, 'A retrospective cohort study of melanoma prevalence stratified by body site in a Regional Australian Population 1994-2017: Site-specific protective mechanisms', Photodermatology Photoimmunology and Photomedicine, 35, pp. 135 - 140, http://dx.doi.org/10.1111/phpp.12436

Frew JW, 2019, 'Complement, hidradenitis suppurativa and pathogen-driven positive selection', British Journal of Dermatology, 180, pp. 685 - 686, http://dx.doi.org/10.1111/bjd.17426

Frew JW, 2019, 'Commentary: Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.00302

Frew JW, 2019, 'We need to talk about Notch: Notch dysregulation as an epiphenomenon in inflammatory skin disease', British Journal of Dermatology, 180, pp. 431 - 432, http://dx.doi.org/10.1111/bjd.17414

Frew JW, 2019, 'Commentary: Hidradenitis Commentary: Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory pathways into a cohensive pathogenic model', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2018.02965

Shavit E; Alavi A; Bechara FG; Bennett RG; Bourcier M; Cibotti R; Daveluy S; Frew JW; Garg A; Hamzavi I; Hoffman LK; Hsaio J; Kirby JS; Lev-Tov H; Martinez E; Micheletti R; Naik HB; Nassif A; Nicholson C; Parks-Miller A; Patel Z; Piguet V; Ramesh M; Resnik B; Sayed C; Schultz G; Siddiqui A; Tan J; Wortsman X; Lowes MA, 2019, 'Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017', Experimental Dermatology, 28, pp. 94 - 103, http://dx.doi.org/10.1111/exd.13849

Frew JW, 2019, 'The hygiene hypothesis, old friends, and new genes', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.00388

Frew JW; Hawkes JE; Krueger JG, 2019, 'Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms', Therapeutic Advances in Chronic Disease, 10, http://dx.doi.org/10.1177/2040622319830646

Frew J; Wu X; Hsiung GY; Feldman HH; Mackenzie IR; Nygaard HB, 2019, 'Generation of an induced pluripotent stem cell line (UBCi001-A) from a presymptomatic individual carrying the R418X progranulin gene mutation', Stem Cell Research, 41, pp. 101582, http://dx.doi.org/10.1016/j.scr.2019.101582

Brand DH; Tree AC; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Chan A; Dayes IS; Henderson D; Brown S; Cruickshank C; Burnett S; Duffton A; Griffin C; Hinder V; Morrison K; Naismith O; Hall E; van As N; Dodds D; Lartigau E; Patton S; Thompson A; Winkler M; Wells P; Lymberiou T; Saunders D; Vilarino-Varela M; Vavassis P; Tsakiridis T; Carlson R; Rodrigues G; Tanguay J; Iqbal S; Winkler M; Morgan S; Mihai A; Li A; Din O; Panades M; Wade R; Rimmer Y; Armstrong J; Panades M; Oommen N, 2019, 'Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial', The Lancet Oncology, 20, pp. 1531 - 1543, http://dx.doi.org/10.1016/s1470-2045(19)30569-8

Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz‐Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram‐Wolff C; Battistella M; Alberti‐Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot‐Barry M; Pham‐Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel‐Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon‐Pennamen M; Battistella M; Climent F; Gonzalez‐Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots A; Hauben E; Bervoets A; Woei‐A‐Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke C; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R, 2019, 'The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients', British Journal of Dermatology, 181, pp. 350 - 357, http://dx.doi.org/10.1111/bjd.17258

Dearnaley D; Griffin CL; Lewis R; Mayles P; Mayles H; Naismith OF; Harris V; Scrase CD; Staffurth J; Syndikus I; Zarkar A; Ford DR; Rimmer YL; Horan G; Khoo V; Frew J; Venkitaraman R; Hall E, 2019, 'Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)', International Journal of Radiation Oncology • Biology • Physics, 103, pp. 605 - 617, http://dx.doi.org/10.1016/j.ijrobp.2018.10.003

Vekic DA; Frew J; Cains GD, 2018, 'Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1', Australasian Journal of Dermatology, 59, pp. 267 - 277, http://dx.doi.org/10.1111/ajd.12770

Frew JW, 2018, 'New therapeutics for itch in dermatomyositis', British Journal of Dermatology, 179, pp. 559 - 560, http://dx.doi.org/10.1111/bjd.16811

Kim E; McCrossin I; Frew JW, 2018, 'HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions', Australasian Journal of Dermatology, 59, pp. 245 - 246, http://dx.doi.org/10.1111/ajd.12754

Vekic DA; Frew JW, 2018, 'Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?', Australasian Journal of Dermatology, 59, pp. e243 - e244, http://dx.doi.org/10.1111/ajd.12767

Wain T; Choy B; Satchell AC; Woods JA; Frew JW, 2018, 'Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets', Jaad Case Reports, 4, pp. 500 - 505, http://dx.doi.org/10.1016/j.jdcr.2018.02.007

Frew JW, 2018, 'Quality-of-Life Measures in Hidradenitis Suppurativa: The Importance of High-Quality Methodology and Standards', Journal of Cutaneous Medicine and Surgery, 22, pp. 368 - 368, http://dx.doi.org/10.1177/1203475418756372

Frew JW; Anstey A, 2018, 'BJD research letters: concise, thought provoking and of general interest', British Journal of Dermatology, 178, pp. 309 - 310, http://dx.doi.org/10.1111/bjd.16162

Frew JW; Vekic DA; Woods JA; Cains GD, 2018, 'Drug-associated hidradenitis suppurativa: A systematic review of case reports', Journal of the American Academy of Dermatology, 78, pp. 217 - 219.e2, http://dx.doi.org/10.1016/j.jaad.2017.08.046

Frew JW; Davidson M; Murrell DF, 2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5

Frew JW; Fallah H, 2017, 'Lichen amyloidosis involving the scalp', Australasian Journal of Dermatology, 58, pp. e260 - e261, http://dx.doi.org/10.1111/ajd.12582

Frew JW; Vekic DA; Woods J; Cains GD, 2017, 'A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa', British Journal of Dermatology, 177, pp. 987 - 998, http://dx.doi.org/10.1111/bjd.15441

Frew JW; Murrell DF, 2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140

Rademaker M; Agnew K; Andrews M; Armour K; Baker C; Foley P; Frew J; Gebauer K; Gupta M; Kennedy D; Marshman G; Sullivan J, 2017, 'Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.', Australas J Dermatol, 59, pp. 86 - 100, http://dx.doi.org/10.1111/ajd.12641

Hunter H; Mellerio J; Frew J; Warren R; Ofenloch R, 2017, 'News and Notices', British Journal of Dermatology, 177, pp. 599 - 601, http://dx.doi.org/10.1111/bjd.15851

Morris S; Scarisbrick J; Frew J; Irwin C; Grieve R; Humber C; Kuciejewska A; Bayne S; Weatherhead S; Child F; Wain M; Whittaker S, 2017, 'The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group', International Journal of Radiation Oncology • Biology • Physics, 99, pp. 627 - 633, http://dx.doi.org/10.1016/j.ijrobp.2017.05.052

Frew JW, 2016, 'Beyond the tip of the iceberg: The role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa', British Journal of Dermatology, 174, pp. 484 - 485, http://dx.doi.org/10.1111/bjd.14349

Frew JW; Henderson CJA; McCrossin ID, 2016, 'The early bird and the worm: a case of cercarial dermatitis', MEDICAL JOURNAL OF AUSTRALIA, 204, pp. 122 - 1230, http://dx.doi.org/10.5694/mja15.00802

Vekic DA; Frew JW; Woods J; Cains GD, 2016, 'Adopting the orphan: The importance of recognising hidradenitis suppurativa as a systemic auto-inflammatory disease', Australasian Journal of Dermatology, 57, pp. 69 - 70, http://dx.doi.org/10.1111/ajd.12287

Frew JW; Henderson CJA; McCrossin ID, 2016, 'The early bird and the worm: a case of cercarial dermatitis', Medical Journal of Australia, 204, pp. 122 - 123, http://dx.doi.org/10.5694/MJA15.00802

Zhao CY; Frew JW; Muhaidat J; Cheung K; Lee P; Poulos V; McCrossin I; Cachia AR; Tefany F; Murrell DF, 2016, 'Chlorophyll-induced pseudoporphyria with ongoing photosensitivity after cessation - a case series of four patients.', J Eur Acad Dermatol Venereol, 30, pp. 1239 - 1242, http://dx.doi.org/10.1111/jdv.13169

Frew JW; Murrell DF; Haber RM, 2015, 'Fifty shades of yellow: A review of the xanthodermatoses', International Journal of Dermatology, 54, pp. 1109 - 1123, http://dx.doi.org/10.1111/ijd.12945

Frew JW; Nguyen RTD, 2015, 'Tattoo-associated mycobacterial infections: an emerging public health issue', Medical Journal of Australia, 203, pp. 223 - 223e.1, http://dx.doi.org/10.5694/MJA15.00098

Frew JW; Parsi K, 2015, 'Adalimumab-induced porokeratosis', Australasian Journal of Dermatology, 56, pp. e80 - e81, http://dx.doi.org/10.1111/ajd.12215

Frew JW; Vekic DA; Woods J; Cains GD, 2015, 'Phenotypic heterogeneity implies heterogeneous pathogenic pathways in hidradenitis suppurativa', Experimental Dermatology, 24, pp. 338 - 339, http://dx.doi.org/10.1111/exd.12648

Frew JW, 2015, 'Multinucleate cell angiohistiocytoma: Clinicopathological correlation of 142 cases with insights into etiology and pathogenesis', American Journal of Dermatopathology, 37, pp. 222 - 228, http://dx.doi.org/10.1097/DAD.0000000000000075

Frew JW; Parsi K, 2014, 'Adalimumab-induced porokeratosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF, 2014, 'Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population', Acta Dermato Venereologica, 94, pp. 442 - 447, http://dx.doi.org/10.2340/00015555-1758

Frew JW, 2014, 'The clinical significance of drug interactions between dermatological and psychoactive medications', Dermatologic Therapy, 27, pp. 1 - 11, http://dx.doi.org/10.1111/dth.12003

Tjokrowidjaja A; Daniel BS; Frew JW; Sebaratnam DF; Hanna AM; Chee S; Dermawan A; Wang CQ; Lim C; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF, 2013, 'The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', British Journal of Dermatology, 169, pp. 1000 - 1006, http://dx.doi.org/10.1111/bjd.12623

Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JCK; Wang CQ; Welsh B; Nijsten T; Murrell DF, 2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972

Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF, 2013, 'A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa', Journal of the American Academy of Dermatology, 69, pp. 898 - 8e7, http://dx.doi.org/10.1016/j.jaad.2013.08.014

Frew JW; Cepeda Valdes R; Fortuna G; Murrell DF; Salas Alanis J, 2013, 'Measuring quality of life in epidermolysis bullosa in Mexico: Cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire', Journal of the American Academy of Dermatology, 69, pp. 652 - 653, http://dx.doi.org/10.1016/j.jaad.2013.04.053

Frew JW; Cepeda-Valdes R; Fortuna G; Salas-Alanis JC; Murrell DF, 2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40

Sebaratnam DF; Venugopal SS; Frew JW; McMillan JR; Finkelstein ER; Martin LK; Murrell DF, 2013, 'Diffuse melanosis cutis: a systematic review of the literature.', J Am Acad Dermatol, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018

Back to profile page